Market Summary
USD152.05+2.44
Market Closed1.63%
ABC Alerts
ABC Stock Price
ABC RSI Chart
ABC Valuation
ABC Price/Sales (Trailing)
ABC Profitability
ABC Fundamentals
ABC Revenue
ABC Earnings
Price Action
52 Week Range
134.73174.63
(Low)(High)
Last 7 days
-1.5%
Last 30 days
-5.7%
Last 90 days
-9.7%
Trailing 12 Months
-0.3%
ABC Financial Health
ABC Investor Care
Peers (Alternatives to AmerisourceBergen)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
UNH | 440.9B | 324.2B | -6.04% | -5.61% | 21.91 | 1.36 | 12.71% | 16.40% |
MCK | 47.6B | 273.9B | -8.61% | 15.39% | 15.14 | 0.17 | 6.57% | 122.45% |
ABC | 30.7B | 241.8B | -5.67% | -0.26% | 17.78 | 0.13 | 9.36% | 7.14% |
CAH | 18.4B | 193.0B | -12.13% | 32.76% | -14.46 | 0.1 | 12.68% | -329.37% |
HSIC | 10.3B | 12.6B | -12.76% | -10.22% | 19.14 | 0.81 | 1.98% | -14.74% |
| MID-CAP | ||||||||
LHCG | 5.2B | 2.3B | 3.17% | 35.63% | 86.23 | 2.28 | 2.85% | -58.05% |
HQY | 5.0B | 831.2M | -11.67% | 3.11% | -84.99 | 6.01 | 12.11% | -862.52% |
AMN | 3.6B | 5.2B | -10.88% | -15.90% | 8.03 | 0.68 | 31.60% | 35.63% |
PDCO | 2.5B | 6.4B | -14.06% | -14.67% | 12.88 | 0.39 | -0.52% | 17.01% |
| SMALL-CAP | ||||||||
ADUS | 1.6B | 951.1M | -7.28% | 30.41% | 34.53 | 1.67 | 10.02% | 1.99% |
RDNT | 1.3B | 1.4B | 12.22% | 10.36% | 120.12 | 0.89 | 8.74% | -56.93% |
OMI | 980.9M | 10.0B | -39.00% | -69.08% | 43.81 | 0.1 | 1.74% | -89.90% |
BKD | 524.3M | 2.8B | -3.12% | -59.80% | -2.2 | 0.19 | 2.43% | -140.13% |
PETQ | 365.3M | 934.1M | 8.79% | -50.13% | -7.58 | 0.39 | 3.77% | -201.92% |
SMED | 170.0M | - | 1.98% | -1.24% | 31.24 | 2.46 | - | - |
Financials for AmerisourceBergen
| Income Statement (Last 12 Months) | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
| Revenue | 1.3% | 241,805 | 238,587 | 236,325 | 229,666 | 221,101 |
| Gross Profit | 1.0% | 8,382 | 8,296 | 8,380 | 8,253 | 7,551 |
| S&GA Expenses | 2.5% | 4,970 | 4,849 | 4,801 | 4,502 | 4,029 |
| EBITDA | 0.0% | 2,574 | 2,574 | 2,736 | 3,168 | - |
| EBITDA Margin | -1.3% | 0.01* | 0.01* | 0.01* | 0.01* | - |
| Earnings Before Taxes | -0.1% | 2,180 | 2,183 | 2,355 | 2,452 | 2,290 |
| EBT Margin | -1.5% | 0.01* | 0.01* | 0.01* | 0.01* | - |
| Net Income | 1.8% | 1,729 | 1,699 | 1,842 | 1,727 | 1,614 |
| Net Income Margin | 0.4% | 0.01* | 0.01* | 0.01* | 0.01* | - |
| Free Cahsflow | -6.8% | 2,057 | 2,207 | 2,061 | 2,851 | - |
| Balance Sheet | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
| Assets | 2.4% | 57,907 | 56,561 | 57,174 | 57,308 | 57,578 |
| Current Assets | 2.8% | 40,708 | 39,590 | 39,745 | 39,410 | 39,379 |
| Cash Equivalents | -50.1% | 1,692 | 3,388 | 3,034 | 2,961 | 3,169 |
| Inventory | 7.9% | 16,780 | 15,556 | 15,823 | 15,515 | 16,294 |
| Net PPE | 0.2% | 2,140 | 2,135 | 2,105 | 2,139 | 2,130 |
| Goodwill | 1.1% | 8,597 | 8,504 | 8,632 | 8,798 | 8,922 |
| Current Liabilities | 3.0% | 44,761 | 43,478 | 43,154 | 42,798 | 41,614 |
| LT Debt, Non Current | 0.5% | 4,656 | 4,632 | 4,640 | 4,647 | 6,413 |
| Shareholder's Equity | 3.2% | 74.00 | 71.00 | 224 | 906 | 601 |
| Retained Earnings | 12.8% | 3,358 | 2,978 | 2,779 | 2,470 | 2,019 |
| Additional Paid-In Capital | 1.4% | 5,737 | 5,659 | 5,628 | 5,600 | 5,547 |
| Shares Outstanding | -1.9% | 202 | 206 | 208 | 209 | 209 |
| Minority Interest | -11.0% | 252 | 283 | 294 | 356 | 360 |
| Cashflow (Last 12 Months) | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
| Cashflow From Operations | -5.7% | 2,550 | 2,703 | 2,548 | 3,347 | 2,627 |
| Share Based Compensation | 13.6% | 106 | 93.00 | 95.00 | 95.00 | 94.00 |
| Cashflow From Investing | -371.3% | -1,736 | -368 | -365 | -6,164 | -6,219 |
| Cashflow From Financing | -48.9% | -2,610 | -1,752 | -1,523 | -340 | 2,391 |
| Dividend Payments | -0.2% | 391 | 392 | 388 | 382 | 376 |
| Buy Backs | 166.9% | 1,291 | 484 | 248 | 11.00 | 26.00 |
Risks for ABC
What is the probability of a big loss on ABC?
30.4%
Probability that AmerisourceBergen stock will be more than 20% underwater in next one year
1.9%
Probability that AmerisourceBergen stock will be more than 30% underwater in next one year.
0%
Probability that AmerisourceBergen stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does ABC drawdown profile look like?
Y-axis is the maximum loss one would have experienced if AmerisourceBergen was unfortunately bought at previous high price.
Drawdowns
Returns for ABC
Cumulative Returns on ABC
13.6%
10-Year Cumulative Returns
9.8%
7-Year Cumulative Returns
10.9%
5-Year Cumulative Returns
20.1%
3-Year Cumulative Returns
What are the long-term rolling returns for ABC?
FIve years rolling returns for AmerisourceBergen.
Annualized Returns
Which funds bought or sold ABC recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-03-15 | B. Riley Wealth Advisors, Inc. | new | - | 373,318 | 373,318 | 0.01% |
2023-03-13 | Claro Advisors LLC | new | - | 217,911 | 217,911 | 0.07% |
2023-03-10 | MATHER GROUP, LLC. | new | - | 212,937 | 212,937 | -% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | reduced | -46.52 | -16,287,500 | 30,909,500 | 0.03% |
2023-03-06 | Rockefeller Capital Management L.P. | added | 4.34 | 1,476,000 | 6,792,000 | 0.03% |
2023-03-03 | TIAA, FSB | reduced | -2.18 | 54,609 | 327,609 | -% |
2023-03-02 | LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA | new | - | 82,855 | 82,855 | -% |
2023-03-01 | SMITHBRIDGE ASSET MANAGEMENT INC/DE | new | - | 478,000 | 478,000 | 0.13% |
2023-02-28 | Voya Investment Management LLC | added | 21.71 | 6,384,970 | 19,405,000 | 0.03% |
2023-02-28 | Trust Investment Advisors | new | - | 224,537 | 224,537 | 0.21% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
ABC Alerts
AmerisourceBergen News
Schedule 13G FIlings of AmerisourceBergen
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Jan 25, 2023 | blackrock inc. | 8.7% | 17,642,496 | SC 13G/A | |
| Jan 10, 2023 | vanguard group inc | 10.01% | 20,345,297 | SC 13G/A | |
| Nov 09, 2022 | walgreens boots alliance, inc. | 19.6% | 39,620,714 | SC 13D/A | |
| May 12, 2022 | walgreens boots alliance, inc. | 25.2% | 52,854,867 | SC 13D/A | |
| Feb 09, 2022 | vanguard group inc | 8.24% | 17,142,380 | SC 13G/A | |
| Feb 03, 2022 | blackrock inc. | 6.3% | 13,036,024 | SC 13G/A | |
| Jun 03, 2021 | walgreens boots alliance, inc. | 28.4% | 58,854,867 | SC 13D/A | |
| Feb 10, 2021 | vanguard group inc | 8.33% | 17,013,279 | SC 13G/A | |
| Jan 29, 2021 | blackrock inc. | 5.4% | 11,049,607 | SC 13G/A | |
| Jan 08, 2021 | walgreens boots alliance, inc. | 27.7% | 56,854,867 | SC 13D/A |
ABC Fair Value
AmerisourceBergen fair value in different scenarios
The table shows the Fair Value estimates for AmerisourceBergen for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
| Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
|---|---|---|---|---|---|
| Very Low Inflation | 128.33 -15.60% | 262.78 72.82% | 482.29 217.19% | 797.45 424.47% | 1213.12 697.84% |
| Current Inflation | 116.92 -23.10% | 236.03 55.23% | 425.25 179.68% | 694.05 356.46% | 1046.65 588.36% |
| Very High Inflation | 102.92 -32.31% | 203.89 34.09% | 358.33 135.67% | 574.68 277.95% | 856.32 463.18% |
Historical AmerisourceBergen Fair Value Estimates
Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price
Recent SEC filings of AmerisourceBergen
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Mar 15, 2023 | 4 | Insider Trading | |
| Mar 15, 2023 | 8-K | Current Report | |
| Mar 13, 2023 | 4 | Insider Trading | |
| Mar 13, 2023 | 4 | Insider Trading | |
| Mar 13, 2023 | 4 | Insider Trading | |
| Mar 13, 2023 | 4 | Insider Trading | |
| Mar 13, 2023 | 4 | Insider Trading | |
| Mar 13, 2023 | 4 | Insider Trading | |
| Mar 13, 2023 | 4 | Insider Trading | |
| Mar 13, 2023 | 4 | Insider Trading |
Latest Insider Trading transactions for ABC
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-03-14 | COLLIS STEVEN H | sold | -1,574,850 | 150 | -10,499 | chairman, president & ceo |
2023-03-14 | COLLIS STEVEN H | acquired | 813,988 | 77.53 | 10,499 | chairman, president & ceo |
2023-03-09 | Miller Redonda | acquired | - | - | 1,334 | - |
2023-03-09 | GOCHNAUER RICHARD W | acquired | - | - | 1,334 | - |
2023-03-09 | Battaglia Silvana | acquired | - | - | 1,211 | executive vice president |
2023-03-09 | DURCAN DERMOT MARK | acquired | - | - | 1,667 | - |
2023-03-09 | McGee Henry Wadsworth III | acquired | - | - | 1,334 | - |
2023-03-09 | NALLY DENNIS M | acquired | - | - | 1,334 | - |
2023-03-09 | Battaglia Silvana | sold (taxes) | -53,850 | 150 | -359 | executive vice president |
2023-03-09 | Kim Lorence H. | acquired | - | - | 1,334 | - |
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
ABC Income Statement
2022-12-31CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | |
| Income Statement [Abstract] | ||
| Revenue | $ 62,846,832 | $ 59,628,810 |
| Cost of goods sold | 60,700,879 | 57,568,451 |
| Gross profit | 2,145,953 | 2,060,359 |
| Operating expenses: | ||
| Distribution, selling, and administrative | 1,290,928 | 1,170,110 |
| Depreciation | 99,542 | 95,585 |
| Amortization | 72,398 | 80,344 |
| Litigation and opioid-related expenses | 12,706 | 32,635 |
| Acquisition, integration, and restructuring expenses | 37,236 | 32,334 |
| Impairment of assets | 0 | 4,946 |
| Operating income | 633,143 | 644,405 |
| Other income, net | (6,328) | (5,172) |
| Interest expense, net | 46,016 | 53,372 |
| Income before income taxes | 593,455 | 596,205 |
| Income tax expense | 117,285 | 146,789 |
| Net income | 476,170 | 449,416 |
| Net loss (income) attributable to noncontrolling interests | 3,575 | (311) |
| Net income attributable to AmerisourceBergen Corporation | $ 479,745 | $ 449,105 |
| Earnings per share: | ||
| Basic (usd per share) | $ 2.35 | $ 2.15 |
| Diluted (usd per share) | $ 2.33 | $ 2.13 |
| Weighted average common shares outstanding: | ||
| Basic (shares) | 204,032 | 208,555 |
| Diluted (shares) | 206,327 | 211,168 |
| Cash dividends declared per share of common stock (usd per share) | $ 0.485 | $ 0.460 |
ABC Balance Sheet
2022-12-31CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2022 | Sep. 30, 2022 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $ 1,692,205 | $ 3,388,189 |
| Accounts receivable, less allowances for returns and credit losses: $1,610,686 as of December 31, 2022 and $1,626,729 as of September 30, 2022 | 18,627,397 | 18,452,675 |
| Inventories | 16,779,873 | 15,556,394 |
| Right to recover assets | 1,529,346 | 1,532,061 |
| Income tax receivable | 85,174 | 172,568 |
| Prepaid expenses and other | 1,994,130 | 487,871 |
| Total current assets | 40,708,125 | 39,589,758 |
| Property and equipment, net | 2,139,782 | 2,135,003 |
| Goodwill | 8,597,145 | 8,503,886 |
| Other intangible assets | 4,429,882 | 4,332,737 |
| Deferred income taxes | 230,437 | 237,571 |
| Other assets | 1,801,522 | 1,761,661 |
| TOTAL ASSETS | 57,906,893 | 56,560,616 |
| Current liabilities: | ||
| Accounts payable | 41,757,949 | 40,192,890 |
| Accrued expenses and other | 2,014,399 | 2,214,592 |
| Short-term debt | 988,275 | 1,070,473 |
| Total current liabilities | 44,760,623 | 43,477,955 |
| Long-term debt | 4,656,029 | 4,632,360 |
| Accrued income taxes | 329,129 | 320,274 |
| Deferred income taxes | 1,633,249 | 1,620,413 |
| Other liabilities | 991,609 | 976,583 |
| Accrued litigation liability | 5,462,695 | 5,461,758 |
| Commitments and contingencies (Note 9) | ||
| Stockholders’ equity: | ||
| Common stock, $0.01 par value - authorized, issued, and outstanding: 600,000,000 shares, 294,174,491 shares, and 202,225,546 shares as of December 31, 2022, respectively, and 600,000,000 shares, 292,700,490 shares, and 206,203,817 shares as of September 30, 2022, respectively | 2,942 | 2,927 |
| Additional paid-in capital | 5,737,106 | 5,658,733 |
| Retained earnings | 3,357,678 | 2,977,646 |
| Accumulated other comprehensive loss | (1,411,918) | (1,830,970) |
| Treasury stock, at cost: 91,948,945 shares as of December 31, 2022 and 86,496,673 shares as of September 30, 2022 | (7,863,939) | (7,019,895) |
| Total AmerisourceBergen Corporation stockholders' deficit | (178,131) | (211,559) |
| Noncontrolling interests | 251,690 | 282,832 |
| Total stockholders' equity | 73,559 | 71,273 |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ 57,906,893 | $ 56,560,616 |